Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ubrelvy
Ubrelvy
New migraine drugs less effective than previous generation of triptan meds: BMJ study
Fierce Pharma
Thu, 09/19/24 - 09:29 pm
migraines
BMJ
Pfizer
Nurtec
AbbVie
Ubrelvy
Eli Lilly
Reyvow
AbbVie's Ubrelvy wards off migraines when used in reaction to early warning signs: study
Fierce Pharma
Thu, 08/29/24 - 06:06 pm
AbbVie
Ubrelvy
migraines
clinical trials
AbbVie’s Migraine Drug Ubrelvy Scores Victory in Phase III Study
BioSpace
Fri, 11/17/23 - 10:00 am
AbbVie
Ubrelvy
ubrogepant
migraines
clinical trials
4 AbbVie brands land on pharma's top TV spenders list for September
Fierce Pharma
Sat, 10/17/20 - 11:46 pm
television ads
DTC ads
AbbVie
Humira
Skyrizi
Rinvoq
Ubrelvy
Docs 'excited' to learn more about new migraine drugs from Biohaven, Lilly and AbbVie: analyst
Fierce Pharma
Thu, 06/25/20 - 10:53 am
migraines
physicians
Biohaven
Eli Lilly
AbbVie
Nurtec ODT
Ubrelvy
Reyvow
Biohaven scores CGRP OK for acute migraine — can the commercial team catch up with Allergan on its debut?
Endpoints
Thu, 02/27/20 - 11:46 pm
Biohaven
FDA
migraines
Nurtec
Allergan
AbbVie
Ubrelvy
Lilly's migraine reliever Reyvow cleared for launch, beating Allergan's rival Ubrelvy to market
Fierce Pharma
Fri, 01/31/20 - 12:14 pm
migraines
Eli Lilly
Reyvow
Allergan
Ubrelvy